A phase I, pharmacokinetic and biological evaluation of a small molecule inhibitor of poly ADP-ribose polymerase-1 [poly(ADP-ribose) polymerase inhibitors], KU-0059436, in patients with advanced tumours

Trial Profile

A phase I, pharmacokinetic and biological evaluation of a small molecule inhibitor of poly ADP-ribose polymerase-1 [poly(ADP-ribose) polymerase inhibitors], KU-0059436, in patients with advanced tumours

Active, no longer recruiting
Phase of Trial: Phase I

Latest Information Update: 26 Oct 2005

At a glance

  • Drugs Olaparib (Primary)
  • Indications Solid tumours
  • Focus Adverse reactions
  • Most Recent Events

    • 26 Oct 2005 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top